术前MRI列线图无创预测胶质瘤总生存的多中心研究
本研究基于多中心1992例弥漫性胶质瘤患者,利用年龄和MRI视觉特征构建术前临床影像列线图,并与基于2021 WHO分类的组织病理模型及两者联合模型比较。外部验证中术前列线图C指数为0.736,高于组织病理模型的0.701,联合模型为0.759。结果表明该术前列线图可为成人弥漫性胶质瘤提供无创的生存预测和风险分层。
要点
- 术前MRI视觉特征结合年龄列线图可无创预测胶质瘤总生存
- 联合组织病理模型预测效能最高,外部验证C指数为0.759
- 列线图风险分层可区分高危与低危患者,HR为5.485
核心结论
- 术前临床影像列线图可为成人弥漫性胶质瘤提供易于获取且可解释的无创术前总生存预测工具
- 联合临床影像与组织病理变量的模型预测性能优于单独使用任一模型
研究设计与样本
- 多中心回顾性研究,共纳入1992例患者,训练集1207例,外部验证集785例
- 采用Cox回归构建预测模型,以年龄和MRI视觉特征为基础变量
- 参考标准为总生存期,以2021 WHO分类中的肿瘤类型和级别作为组织病理变量
关键影像表现/征象
- 术前列线图外部验证C指数为0.736,组织病理模型为0.701,联合模型为0.759
- 术前列线图1年、3年、5年时间依赖AUC分别为0.764、0.850、0.900
- 组织病理模型1年、3年、5年时间依赖AUC分别为0.725、0.822、0.918
- 联合模型1年、3年、5年时间依赖AUC分别为0.796、0.866、0.930
- 高风险组总生存期较短,风险比为5.485(95%CI 4.261-7.062,P<0.0001)
诊断标准与关键数值
- 高风险组判定采用最大化选择秩统计量确定风险评分截断值
- 术前列线图外部验证C指数为0.736,与组织病理模型比较P<0.001
- 联合模型外部验证C指数为0.759,与术前列线图比较P<0.001
临床应用与阅片要点
- 术前列线图可用于在未取得组织样本时对弥漫性胶质瘤患者进行总生存预测
- 结合年龄和MRI视觉特征即可完成风险分层,便于在日常报告中进行预后提示
- 高风险与低风险分层可辅助治疗决策和患者沟通,但需结合组织病理结果进一步验证
局限性
- 回顾性研究设计,存在选择偏倚可能
- 术前列线图依赖MRI视觉特征判读,观察者间一致性未说明
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Glioma prognostication relies on histopathological and molecular assessment requiring tissue sampling. Accessible tools for noninvasive preoperative prognostication remain limited.
METHODS: This multicenter retrospective study included 1992 patients (1207 in the training dataset [TD] and 785 in the external validation dataset [EVD]). A preoperative clinicoradiological nomogram (PCR nomogram) was developed using Cox regression with age and visual magnetic resonance imaging features. A histopathology-based model incorporated tumor type and grade according to the 2021 World Health Organization (WHO) classification, and a clinicoradiological-histopathological (CRH) model combined these histopathological variables with the PCR nomogram variables. Performance was evaluated using the C-index and time-dependent area under the receiver operating characteristic curve (tdAUROC). Maximally selected rank statistics were used to define a risk-score cutoff for high- and low-risk groups. Overall survival (OS) was compared using Kaplan-Meier curves and the log-rank test.
RESULTS: In the EVD, the PCR nomogram achieved a C-index of 0.736, compared with 0.701 for the histopathology-based model (P < 0.001) and 0.759 for the CRH model (P < 0.001). The PCR nomogram's 1-, 3-, and 5-year tdAUROCs were 0.764, 0.850, and 0.900, compared with 0.725, 0.822, and 0.918 for the histopathology-based model and 0.796, 0.866, and 0.930 for the CRH model, respectively. High-risk patients showed shorter OS than low-risk patients (hazard ratio, 5.485; 95% confidence interval, 4.261-7.062; P < 0.0001).
CONCLUSIONS: The PCR nomogram may provide a readily accessible and interpretable tool for noninvasive preoperative OS prediction and prognostic stratification in adults with diffuse glioma.
引用
- Liu, Qiu, Jin, et al. Preoperative magnetic resonance imaging-based nomogram for predicting overall survival in patients with glioma: a multicenter study. Eur J Radiol. 2026. PMID: 42800241. doi:10.1016/j.ejrad.2026.113257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。